The Hindu
The collaboration will be instrumental in advancing clinical development of a dengue monoclonal antibody in Brazil and potentially other endemic countries in Southeast Asia, with a focus on making treatment affordable and accessible, SII Executive Director Dr. Prasad Kulkarni said…
Read More
SII, DNDi partner for expanding human trials for dengue treatment
Bong Stoval
23:24
The collaboration will be instrumental in advancing clinical development of a dengue monoclonal antibody in Brazil and potentially other endemic countries in Southeast Asia, with a focus on making treatment affordable and accessible, SII Executive Director Dr. Prasad Kulkarni said…